Consolidated Balance Sheets (Parenthetical) - USD ($) |
Mar. 31, 2023 |
Dec. 31, 2022 |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Investment, cost | $ 1,062,976,000 | [1] | $ 1,059,886,000 | [2] | ||||||||||||||||
Deferred financing costs, accumulated amortization | $ 2,715,000 | $ 2,413,000 | ||||||||||||||||||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | ||||||||||||||||||
Common stock, shares authorized (in shares) | 450,000,000 | 450,000,000 | ||||||||||||||||||
Common stock, shares issued (in shares) | 80,150,887 | 80,105,999 | ||||||||||||||||||
Common stock, shares outstanding (in shares) | 80,150,887 | 80,105,999 | ||||||||||||||||||
Unsecured Debt | Series A Notes due 2026 | ||||||||||||||||||||
Debt instrument, par value | $ 150,000,000 | $ 150,000,000 | ||||||||||||||||||
Control investments | ||||||||||||||||||||
Investment, cost | 31,409,000 | [1],[3] | 31,120,000 | [2],[4] | ||||||||||||||||
Affiliate investments | ||||||||||||||||||||
Investment, cost | 242,145,000 | [1],[5] | 241,565,000 | [2],[6] | ||||||||||||||||
Non‑Control/Non‑Affiliate investments | ||||||||||||||||||||
Investment, cost | $ 789,422,000 | [1],[7] | $ 787,201,000 | [2],[8] | ||||||||||||||||
|